Entering text into the input field will update the search result below

Cara Therapeutics down 8% after hours following Q4 2021 earnings misses

Mar. 01, 2022 5:37 PM ETCara Therapeutics, Inc. (CARA)By: Jonathan Block, SA News Editor1 Comment

Rolled newspaper with the headline Quarterly Results

Zerbor/iStock via Getty Images

  • Shares of Cara Therapeutics (NASDAQ:CARA) are down 8% in after-hours trading after the company's Q4 2021 results missed on the top and bottom lines.
  • In the quarter, the company swung to a net loss of $33.4M from net income

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.